It’s a classic medicine cabinet in Spanish homes, although a prescription is needed to purchase it. It is used, according to the information leaflet, for the treatment of moderate or intense acute postoperative or post-traumatic pain, of colic type or of tumor origin. This analgesic It is also used in case of high fever that does not respond to other measures or other medicines. We are talking about Nolotil, the best-selling medicine in our country in the last 12 months (data updated to September 2024), according to data published by the Authority Medicine Observatory of the Business Federation of Spanish Pharmacists (FEFE).
In the top ten, behind Nolotil, with 28.6 million units sold, they appear in this order: Oven 100an antiplatelet agent used to prevent blood clots (19.1 million); painkillers Paracetamol Kern (18.8), Paracetamol Cinfa (16.7) y Enantio (16.3); the gastric protector Omeprazole Cinfamed (10.3), the antithyroid Eutirox (9.8), the antihypertensive Bisoprolol standard (7,7); the anxiolytic Norma Loracepa (7.4) and the diuretic Furosemide Uxa (7,4).
Among the 30 best-selling drugs per unit, there are 9 analgesics, 5 anxiolytics and 3 hypocholesterolemic agents.
On the other hand, the ranking of higher billed drugs In the lead is the anticoagulant Eliquis (200.5 million euros), followed by the antidiabetics Jardiance (138.4) and Ozempic (137.6); the anticoagulant Xarelto (126.2); Forxiga (113.2) for heart failure; the anti-diabetic Rybelsus; Entresto (112.5) for heart failure; the anticoagulant Lixiana (111.5), the antidiabetic Trulicity (105.5); and Prolia (96.3) for osteoporosis.
Among the 30 with the highest turnover there are 10 antidiabetics, 5 anticoagulants, 3 antiasthmatics and 2 hypocholesterolemics. There are no coincidences between the 30 best-selling drugs in units and by billing.
Interview Between Time.news Editor and Medical Expert on the Popularity of Nolotil in Spain
Time.news Editor (TNE): Welcome to Time.news, where we explore the latest trends in health and medicine. Today, we have Dr. Elena García, a renowned pharmacologist and pain management expert. Thank you for joining us, Dr. García.
Dr. Elena García (EG): Thank you for having me! I’m excited to discuss this topic.
TNE: Let’s dive right in. Nolotil has emerged as the best-selling medicine in Spain over the last year. What do you think drives its popularity?
EG: Nolotil, or metamizole, is quite effective in managing moderate to severe pain, especially after surgeries or trauma. Its ability to alleviate colic-type pain and reduce high fever, particularly when other medications fail, makes it a go-to option for many healthcare professionals.
TNE: Interesting! It’s noteworthy that Nolotil requires a prescription for purchase in Spain. Does this impact how it’s perceived and used by the public?
EG: Absolutely. The prescription requirement adds a layer of trust and responsibility to its use. Patients are typically advised by healthcare providers, which ensures that they are using the medication appropriately. However, it also means that access can be limited compared to over-the-counter pain relievers.
TNE: Given that it’s often used for acute postoperative or post-traumatic pain, how does Nolotil compare to other analgesics in terms of efficacy and safety?
EG: Nolotil is quite powerful and is effective for many patients. However, it is important to note that it can have side effects, including the risk of agranulocytosis, a serious condition affecting white blood cell counts. This is why monitoring and proper medical guidance are crucial when patients are prescribed Nolotil.
TNE: Such a severe side effect certainly raises concerns. What advice would you give to patients who are looking to manage their pain with medications like Nolotil?
EG: Patients should always follow their healthcare provider’s guidance when taking medications. It’s vital to communicate openly about your pain levels and any side effects you experience. If Nolotil is prescribed, ensure regular check-ups and discuss any concerns with your doctor.
TNE: In light of recent trends, do you foresee any changes in the use of Nolotil or similar analgesics in the coming years?
EG: Pain management continues to evolve, with an increasing focus on personalized medicine. I believe we may see a rise in multimodal pain strategies that incorporate Nolotil alongside other therapies, both pharmacological and non-pharmacological, to enhance effectiveness while minimizing risks.
TNE: That’s a comprehensive view! Lastly, how can healthcare systems better educate the public on the safe use of prescription medications like Nolotil?
EG: Education is key. Healthcare providers must take the initiative to inform patients about the risks and benefits of medications. Public health campaigns can also raise awareness, ensuring that patients understand when to seek medical help, the importance of adhering to prescribed therapies, and recognizing potential side effects.
TNE: Thank you, Dr. García, for sharing your valuable insights on Nolotil and pain management! It’s crucial for the public to stay informed about their health.
EG: Thank you for having me. It’s been a pleasure discussing this important topic!
